Lord, Abbett & Co. LLC Eye Point Pharmaceuticals, Inc. Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 07, 2024	SELL	$19.93 - $29.71 $2.56 Million - $3.81 Million	-128,407 Reduced 34.61%	242,580 $5.02 Million
Q1 2024 May 09, 2024	SELL	$19.93 - $29.71 $2.56 Million - $3.81 Million	-128,407 Reduced 34.61%	242,580 $5.02 Million
Q4 2023 Oct 07, 2024	BUY	$5.71 - $24.13 $2.12 Million - $8.95 Million	370,987 New	370,987 $8.57 Million
Q4 2023 Feb 12, 2024	BUY	$5.71 - $24.13 $2.12 Million - $8.95 Million	370,987 New	370,987 $8.57 Million

152

57.9M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.